EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy

Laís Teodoro Da Silva iD, Bruna Tiaki Tiyo iD, Silvia de Jesus Mota iD, Marina Mazzilli Ortega iD, Gabriela Justamante Handel Schmitz iD, Noemi Nosomi Taniwaki iD, Gislene Mitsue Namiyama Nishina iD, Alberto José da Silva Duarte iD, Telma Miyuki Oshiro iD

Journal of Immunology Research · 2024

DOI: 10.1155/2024/6817965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Laís Teodoro Da Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation in Dermatology and Immunodeficiencies (LIM-56) Clinical Hospital HCFMUSP Faculty of Medicine University of Sao Pa…. Hauptthemen laut MEDLINE: Dendritic Cells, Monocytes, Cell Differentiation, Immunotherapy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic vaccines based on monocyte‐derived dendritic cells have been shown to be promising strategies and may act as complementary treatments for viral infections, cancers, and, more recently, autoimmune diseases. Alpha‐type‐1‐polarized dendritic cells (aDC1s) have been shown to induce type‐1 immunity with a high capacity to produce interleukin‐12p70 (IL‐12p70). In the clinical use of cell‐based therapeutics, injectable solutions can affect the morphology, immunophenotypic profile, and viability of cells before delivery and their survival after injection. In this sense, preparing a cell suspension that maintains the quality of aDC1s is essential to ensure effective immunotherapy. In the present study, monocytes were differentiated into aDC1s in the presence of IL‐4 and GM‐CSF. On day 5, the cells were matured by the addition of a cytokine cocktail consisting of IFN‐ α , IFN‐ γ , IL‐1 β , TNF‐ α , and Poly I:C. After 48 hr, mature aDC1s were harvested and suspended in two different solutions: normal saline and Ringer’s lactate. The maintenance of cells in suspension was evaluated after 4, 6, and 8 hr of storage. Cell viability, immunophenotyping, and apoptosis analyses were performed by flow cytometry. Cellular morphology was observed by electron microscopy, and the production of IL‐12p70 by aDC1s was evaluated by ELISA. Compared with normal saline, Ringer’s lactate solution was more effective at maintaining DC viability for up to 8 hr of incubation at 4 or 22°C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsMonocytesCell DifferentiationImmunotherapyCell SurvivalInterleukin-12HumansImmunophenotypingCytokinesCells, CulturedApoptosisInjections

Substanzen

Interleukin-12Cytokines

Autor:innen und Institutionen

  • Laboratory of Medical Investigation in Dermatology and Immunodeficiencies (LIM-56) Clinical Hospital HCFMUSP Faculty of Medicine University of Sao Paulo, Sao Paulo, SP, Brazil.
  • Electron Microscopy Nucleus Adolfo Lutz Institute, Sao Paulo, Brazil.

ORCID-Profile: Laís Teodoro Da Silva, Bruna Tiaki Tiyo, Silvia de Jesus Mota, Marina Mazzilli Ortega, Gabriela Justamante Handel Schmitz, Noemi Nosomi Taniwaki, Gislene Mitsue Namiyama Nishina, Alberto José da Silva Duarte, Telma Miyuki Oshiro

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Teodoro Da Silva, L., Tiaki Tiyo, B., de Jesus Mota, S., Mazzilli Ortega, M., Justamante Handel Schmitz, G., Nosomi Taniwaki, N., Mitsue Namiyama Nishina, G., José da Silva Duarte, A., & Miyuki Oshiro, T. (2024). Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy. Journal of Immunology Research. https://doi.org/10.1155/2024/6817965

Vancouver

Teodoro Da Silva L, Tiaki Tiyo B, de Jesus Mota S, Mazzilli Ortega M, Justamante Handel Schmitz G, Nosomi Taniwaki N, et al. Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy. Journal of Immunology Research. 2024. doi:10.1155/2024/6817965

BibTeX
@article{TeodoroDaSilva2024,
  author = {Teodoro Da Silva, Laís and Tiaki Tiyo, Bruna and de Jesus Mota, Silvia and Mazzilli Ortega, Marina and Justamante Handel Schmitz, Gabriela and Nosomi Taniwaki, Noemi and Mitsue Namiyama Nishina, Gislene and José da Silva Duarte, Alberto and Miyuki Oshiro, Telma},
  title = {Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy},
  journal = {Journal of Immunology Research},
  year = {2024},
  doi = {10.1155/2024/6817965}
}
Kostenlos starten →